A language takes work off your hands, gives it to a compiler, runtime, or toolchain, and charges you somewhere else.

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an ...

Recursion, Roche, and its Genentech subsidiary have announced plans to co-develop a neuroscience discovery program based on ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

News headlines Recursion Pharmaceuticals reported mixed Q2 2026 results, showing a $7.67 million revenue decline from last year. The company announced significant clinical advancements and strategic ...